Published in Vaccine Weekly, September 19th, 2001
If endorsed for human use, the vaccine, based on the F1- and V- antigens of Yersinia pestis, could help overcome some of the problems associated with current plague vaccines
"Plague still occurs throughout the world today, though for reasons that are not fully understood pandemics of disease do not develop from these outbreaks," wrote R.W. Titball and colleagues in Vaccine.
Although bubonic plague usually can be treated with antibiotics,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2001-09-19)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.